JOAN LAPOINTE-KELTO: Open Payments
NPI 1477971273 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,159 in 61 payments from 18 companies in 2025. Trend: 2023 $29 · 2024 $362 · 2025 $1,159
Food & beverage: $1,159
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $324 |
| Novo Nordisk Inc | 9 | $216 |
| ABBVIE INC. | 15 | $168 |
| Aimmune Therapeutics, Inc. | 3 | $83 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $65 |
| Exact Sciences Corporation | 3 | $50 |
| Amgen Inc. | 3 | $46 |
| Renalytix AI, Inc. | 1 | $24 |
| Boston Scientific Corporation | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
Products named: AIRSUPRA, Wegovy, ZENPEP, BREZTRI, VRAYLAR, QULIPTA, XIFAXAN, Cologuard Collection Kit.
Industry payments across AZ — which companies pay providers there.
